Oligonucleotide-Linked Antibody Detection System
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing immunoassay technologies face challenges with label interference and variability in antibody binding, particularly when using fluorescent dyes and PCR amplification, which affect sensitivity and accuracy.
Innovation Solution
Attaching an oligonucleotide to antibodies instead of conventional labels, allowing for the use of labeled complementary oligonucleotides for detection, enabling flexible label selection and improved energy transfer for enhanced sensitivity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Difficulty of detecting and measuring
If a label is attached directly to an antibody, then detection capability is provided, but the antibody's binding ability is interfered with and quenching occurs
Solution Approach 1:
An oligonucleotide is introduced as an intermediary between the antibody and the fluorescent label. The antibody is conjugated to the oligonucleotide instead of directly to the label, which prevents the label from interfering with antibody binding and avoids quenching effects. The oligonucleotide acts as a spacer that maintains the antibody's functional integrity while still enabling detection through the attached label.
Solution Approach 2:
The detection system is segmented into three distinct components: the antibody (for specific binding), the oligonucleotide (as a linker/spacer), and the fluorescent label (for detection). This segmentation allows each component to perform its function optimally without interfering with the others, resolving the contradiction between detection capability and binding ability.
2Measurement precision
If PCR amplification is used to detect oligonucleotide-conjugated antibodies, then sensitivity is improved, but additional time is required and quantitative accuracy is reduced
Solution Approach 1:
The PCR amplification step is extracted and replaced with a direct fluorescent detection method. Instead of using PCR to amplify the oligonucleotide sequence for detection, the system uses fluorescently labeled oligonucleotides that bind directly to the oligonucleotide-conjugated antibodies, providing sensitive detection without the time-consuming amplification process.
Solution Approach 2:
The mechanical/chemical amplification process of PCR is replaced with an optical detection system using fluorescent labels. This substitution eliminates the need for thermal cycling and amplification steps while maintaining or improving detection sensitivity through the high signal-to-noise ratio of fluorescent detection.
3Difficulty of detecting and measuring
If conventional chemical labels are used, then detection is enabled, but flexibility in label selection is limited and energy transfer applications are restricted
Solution Approach 1:
The oligonucleotide serves as a universal platform that can accommodate multiple different fluorescent labels and energy transfer dye pairs. By conjugating the antibody to the oligonucleotide rather than directly to the label, the system gains universality in label selection, allowing researchers to choose from a wide range of fluorescent dyes and energy transfer systems without re-engineering the antibody conjugation chemistry.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach simplifies the use of energy transfer dye pairs, reduces label interference, and provides quantitative measurements of analytes with reduced assay time and variation, improving the sensitivity and reliability of immunoassays.
Implementation Method 1
hybridizing a labeled, complementary oligonucleotide to the conjugated oligonucleotide
Implementation Method 2
use energy transfer between fluorescent dyes to increase Stokes shift and improve assay sensitivity
Data Source
AI summary
Methods for determining the presence of an analyte in a sample are disclosed, in which a capture agent is bound to the analyte at a first epitope and a detection agent is bound at a second epitope, and in which the detection agent includes an oligonucleotide to which a labeled, complementary oligonucleotide can be hybridized.